UNSPSC 51271618: Ropivacaine

This classification denotes an immunosuppressant with the molecular formula C17H26N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7IO5LYA57N, chemically known as n-(2,6-dimethylphenyl)-1-propyl-piperidine-2-carboxamide but generally known as ropivacaine, which bears US NIH Compound Identifier 71273. European Medicines Agency schedules Ropivacaine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10382MIG.

UNSPSC 51271618 Ropivacaine, a Commodity code, covers the procurement of ropivacaine, a local anesthetic agent used in medical and surgical settings. State and local governments acquire ropivacaine primarily through their public health departments, correctional health services, emergency medical services (EMS), and hospital systems for use in regional anesthesia, nerve blocks, and infiltration anesthesia during minor surgical procedures, dental work, and pain management in correctional and detention facilities. The product is typically purchased as injectable solutions in various concentrations and volumes, often through standing orders or blanket purchase agreements that serve multiple departments or facilities within a jurisdiction.

The source provided contains no recent state and local contract opportunities tagged to this code and therefore offers no data on issuing-body mix, geographic concentration, or representative recent solicitations.